Clinical Update on Checkpoint Inhibitor Therapy for Conjunctival and Eyelid Melanoma
- PMID: 32205655
- PMCID: PMC8059069
- DOI: 10.1097/IIO.0000000000000308
Clinical Update on Checkpoint Inhibitor Therapy for Conjunctival and Eyelid Melanoma
Conflict of interest statement
The authors declare that they have no conflicts of interest to disclose.
Figures


References
-
- Shields CL, Chien JL, Surakiatchanukul T, et al. Conjunctival tumors: review of clinical features, risks, biomarkers, and outcomes—The 2017 J. Donald M. Gass Lecture. Asia Pac J Ophthalmol (Phila). 2017;6:109–120. - PubMed
-
- Seregard S, Kock E. Conjunctival malignant melanoma in Sweden 1969-1991. Acta Ophthalmol (Copenh). 2009;70:289–296. - PubMed
-
- Esmaeli B Patterns of regional and distant metastasis in patients with conjunctival melanoma Experience at a cancer center over four decades. Ophthalmology. 2001;108:2101–2105. - PubMed
-
- Vaziri M, Buffam FV, Martinka M, et al. Clinicopathologic features and behavior of cutaneous eyelid melanoma 1 1. Ophthalmology. 2002;109:901–908. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical